A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width Y Bozkaya, B Kurt, F Gürler International journal of clinical oncology 24, 798-806, 2019 | 43 | 2019 |
Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: asystematic literature review of individual patients' data A Erden, A Fanouriakis, L Kiliç, A Sari, B Armağan, E Bilgin, YZ Şener, ... Turkish Journal of Medical Sciences 50 (2), 281-290, 2020 | 17 | 2020 |
Sinonasal SMARCB1 (INI1) deficient carcinoma with yolk sac tumor differentiation: a case report and treatment options B Hazir, B Şímșek, A Erdemír, F Gürler, O Yazici, Y Kizil, U Aydíl Head and Neck Pathology 16 (2), 596-601, 2022 | 14 | 2022 |
The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer. A İLhan, F Gurler, F Yilmaz, E Eraslan, M Dogan European Review for Medical & Pharmacological Sciences 27 (5), 2023 | 10 | 2023 |
Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment F Gürler, A İlhan, DC Güven, O Turhan, BK İnci, O Sütçüoğlu, F Yildiz, ... Anti-cancer drugs 33 (1), e477-e485, 2022 | 7 | 2022 |
Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma F Gürler, DC Güven, E Aydemir, O Sütçüoğlu, BK Inci, Z Arik, Ş Yalçin, ... Turkish Journal of Medical Sciences 52 (5), 1559-1568, 2022 | 4 | 2022 |
Current status of biosimilars in Turkey: a survey among medical oncologists F Gürler, DD Kasım, B Kurt İnci, O Sütçüoğlu, O Ünsal, V Aslan, G Tahtacı, ... Journal of Oncology Pharmacy Practice 28 (7), 1516-1523, 2022 | 3 | 2022 |
Pandemi Sürecinde Kanser Tanı, Tedavi, Takibinde Karşılaşılacak Sorunlar ve Muhtemel Değişiklikler AÖ Bediz KURT İNCİ, Fatih GÜRLER Kanser ve Covid-19 Pandemisi Özel Sayısı 1, p.69-73, 2020 | 3* | 2020 |
SAT0567 Demographic, Clinic and Laboratory Features of 755 Patients with Neonatal Lupus Erythematosus: Systematic Review A Erden, L Kilic, E Bilgin, S Ceylan, B Hymabaccus, YZ Sener, F Gürler, ... Annals of the Rheumatic Diseases 75 (Suppl 2), 874-874, 2016 | 2 | 2016 |
Prognostic significance of nadir PSA value and time to nadir PSA in patients with metastatic castration-naive prostate cancer receiving first-line hormonotherapy BK İnci, F Gürler, O Sütcüoğlu, V Baştuğ, A Üner, A Özet, N Özdemir Journal of cancer research and therapeutics 19 (Suppl 2), S845-S850, 2023 | 1 | 2023 |
Tam Kan Sayımı Parametreleri ile İleri Evre Mide Kanseri Olan Hastaların Prognozunu Tahmin Edilebilir Mi? O Sütçüoğlu, A Fincan, F Gürler, BK İnci, NY Özdemir Turkish Journal of Clinics and Laboratory 14 (2), 243-245, 2023 | 1 | 2023 |
How long does crizotinib work? a rare case of recurrent inflammatory myofibroblastic tumor HC Albayrak, F Gürler, O Sütçüoğlu, N Akyürek, A Özet Anti-cancer drugs 33 (1), 109-111, 2022 | 1 | 2022 |
The role of serum albumin/globulin ratio in combination with prognostic risk indexes of febrile neutropenia O Sütcüoğlu, O Akdoğan, F Gürler, B Kurt İnci, N Özdemir, A Özet, ... International Journal of Clinical Practice 75 (7), e14185, 2021 | 1 | 2021 |
Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality O Sütcüoğlu, O Akdoğan, BK İnci, F Gürler, N Özdemir, O Yazıcı Supportive Care in Cancer 29, 1047-1053, 2021 | 1 | 2021 |
The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer Y Açikgoz, F Gurler, BK Inci, Y Ergun, G Ucar, M Dirikoc, SA Esen, ... Medicine 99 (48), e23168, 2020 | 1 | 2020 |
1473P Parameters of complete blood count might predict the prognosis of patients with advanced gastric cancer O Sutcuoglu, A Fincan, F Gürler, BK Inci, NÖ Yıldırım Annals of Oncology 31, S919-S920, 2020 | 1 | 2020 |
Anti-Ro/La ilişkili konjenital kalp bloğunda prednisolonun uygunsuz kullanımı ve tedavi protokollerindeki heterojenite: 492 vakanın gözden geçirilmesi. A Erden, L Kılıç, A Sarı, B Armağan, E Bilgin, S Ceylan, YZ Şener, ... Journal of Turkish Society for Rheumatology 11 (1), 2019 | 1 | 2019 |
The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer O Akdogan, B Ogut, O Sutcuoglu, A Sert, F Gurler, N Akyurek, N Ozdemir, ... BMC cancer 24 (1), 1-9, 2024 | | 2024 |
Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study K Bir Yücel, M Uğraklı, S Sekmek, N Yıldırım, F Gürler, O Yazıcı, A Özet, ... Current Medical Research and Opinion 40 (7), 1137-1143, 2024 | | 2024 |
A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A … F Gürler, F Tay, Z Sucuoğlu İşleyen, T Yerlikaya, E Hendem, SA Esen, ... Cancer Medicine 13 (14), e70002, 2024 | | 2024 |